Use of piperazine compounds as immunopotentiating agents

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544360, 544372, 544365, C07D40300, C07D40100, A61K 31495

Patent

active

044204817

ABSTRACT:
The present invention relates to a novel piperazine compound represented by the following general formula (I): ##STR1## wherein R stands for an alkyl or phenyl group, and n is a number of 4 or 5.
These compounds are valuable as an immunopotentiators, such as for the treatment of chronic rheumatoid arthritis and other diseases accompanied by reduction or abnormal change of immune function.

REFERENCES:
patent: 3133067 (1964-05-01), Archer
patent: 3250771 (1966-05-01), Leonard et al.
patent: 3509171 (1970-04-01), Welstead et al.
Baltzly et al., Journal of American Chem. Soc., vol. 66, pp. 263-266, (1944), "The Preparation of N-Mono-Substituted & Unsymmetrically Disubstituted Piperazines.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Use of piperazine compounds as immunopotentiating agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of piperazine compounds as immunopotentiating agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of piperazine compounds as immunopotentiating agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-804126

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.